Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730233 | SCV000857958 | likely benign | not specified | 2018-09-11 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000730233 | SCV000966538 | likely benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Arg1576Arg in Exon 09 of TRIOBP: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 0.5% (15/3154) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs112874177). |
Labcorp Genetics |
RCV000901476 | SCV001045848 | benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000901476 | SCV001767755 | likely benign | not provided | 2020-10-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000901476 | SCV005206434 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003928226 | SCV004738834 | likely benign | TRIOBP-related disorder | 2019-05-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |